Metformin

Type: Product

Name: Metformin

First reported 11 hours ago - Updated 11 hours ago - 1 reports

Popular diabetes drug does not improve survival rates after cancer: Study

(NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may ... [Published NewsRX - 11 hours ago]

Entities: Diabetes, Drugs, Cancer, Metformin

First reported 11 hours ago - Updated 11 hours ago - 1 reports

Recent Findings in Hormone Research Described by Researchers from University of Tehran

(NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Investigators publish new report on Hormone Research. According to news reporting out of Tehran, Iran, by NewsRx editors, research stated, "The aim of the study was to assess the effects ... [Published NewsRX - 11 hours ago]

Entities: University of Tehran, Hormone, Metformin, Diabetes, randomized clinical trial

First reported 11 hours ago - Updated 11 hours ago - 1 reports

University of Tehran

New Peptide Science Study Results Reported from University of Tehran

(NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Investigators publish new report on Peptide Science. According to news reporting out of Tehran, Iran, by NewsRx editors, research stated, "To assess the effects of two commonly used ... [Published NewsRX - 11 hours ago]

Entities: Peptide, University of Tehran, Pioglitazone, Metformin

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Insulin's Place In Treatment of Type 2 Diabetes

Insulin associated with increased risk for major adverse cardiac events, first cancer, or mortality....A recent study conducted in the United Kingdom set out to characterize the risk of adverse events associated with the use of variable glucose-lowering ... [Published Diabetes in Control - May 24 2013]

Entities: Insulin, Metformin, Diabetes Type II, Sulfonylurea, Mortality

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Type 2 Diabetes Progresses Faster in Kids, Study Finds

Font SizeAAAType 2 Diabetes Progresses Faster in Kids: StudyHigh blood pressure, other complications seen in adolescenceWebMD News from HealthDayBy Serena GordonHealthDay ReporterTHURSDAY, May 23 (HealthDay News) -- is more aggressive in children than ... [Published WebMD - May 24 2013]

Entities: Diabetes Type II, Metformin, American Diabetes Association, Diabetes

First reported May 24 2013 - Updated May 24 2013 - 3 reports

Youth with type 2 diabetes at much higher risk for heart, kidney disease

) The news about youth and diabetes keeps getting worse. The latest data from the national TODAY diabetes study shows that children who develop Type 2 diabetes are at high risk to develop heart, kidney and eye problems faster and at a higher rate than ... [Published Bio-Medicine - May 24 2013]

Entities: Diabetes Type II, Jane Lynch, Metformin

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Obamacare strikes home

Some years ago I was diagnosed with type 2 diabetes, which I keep under control using an inexpensive generic drug (Metformin) and diet. To keep track of my blood sugar level I test it with a device that uses little disposable "test strips.". My doctor ... [Published Berkshire Eagle - May 24 2013]

Entities: Obamacare, Metformin, Generic Drug

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Coroner calls for better protocols

The Otago-Southland coroner, David Crerar, has recommended changes to protocols in dispensing medication, in the wake of a medicine mix-up contributing to the death of an elderly Ranfurly man.Mr Crerar found Nihe Pahau Paku (Eru) Te Weehi (73) died on ... [Published Otago Daily Times - May 23 2013]

Entities: Joseph Stevenson, Ranfurly (New Zealand), Dispensing, Blister, Metformin

First reported May 23 2013 - Updated May 23 2013 - 1 reports

Fetuses Drugged in Attempt to Prevent Obesity

Trying to make newborns healthy by drugging them before they’re born is pure insanity—but that’s exactly what’s happening in a string of studies. The diabetes drug, metformin, is being trialed on overweight pregnant women. Concerns of birth defects are ... [Published Gaia Health - May 23 2013]

Entities: Metformin, Obesity, Drugs

First reported May 22 2013 - Updated May 23 2013 - 2 reports

NIH Funds Studies to Improve Prediabetes and Type 2 Diabetes Treatment

Trials for adults and youth compare treatments in newly diagnosed subjects (May 22)The National Institutes of Health (NIH) is looking for volunteers to participate in one of three clinical trials to improve and preserve the production of insulin in people ... [Published PT Community - May 23 2013]

Entities: Metformin, National institutes of Health, Diabetes Type II, Prediabetes

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Human medicines European Public Assessment Report (EPAR): Competact, pioglitazone / metformin, Revision: 11, Authorised

[Published Pending EC decisions and European Public Assess ... - May 21 2013]

Entities: Pioglitazone, Metformin

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes

SOURCE Elcelyx TherapeuticsSAN DIEGOElcelyx has not changed the way metformin works but instead, has discovered how and where metformin works and has leveraged that understanding to develop an improved product. Elcelyx believes metformin's primary site ... [Published KiiiTV3.com - May 20 2013]

Entities: Elcelyx Therapeutics Inc, Metformin, Diabetes Type II, Phase IIb, Glucose

Quotes

...According to news reporting out of Tehran, Iran, by NewsRx editors, research stated, "To assess the effects of two commonly used oral hypoglycemic medications metformin and pioglitazone on serum concentrations of omentin and leptin in patients with newly diagnosed type 2 diabetes. In a clinical trial setting (NCT01593371), patients were randomly allocated to either metformin 1000 mg daily (n =41), or pioglitazone 30 mg daily (n = 50)."

New Peptide Science Study Results Reported from University of Tehran [Published NewsRX - 11 hours ago]

Our news journalists obtained a quote from the research from the University of Tehran, "Patients were randomly assigned to either metformin 1 000 mg daily plus advice for exercise and lifestyle... We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3."

Recent Findings in Hormone Research Described by Researchers from University of Tehran [Published NewsRX - 11 hours ago]

Earlier this month, Eli Lilly halted development of Phase 3 candidate enzastaurin. The diffuse large B-cell lymphoma [dlbcl] drug "failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of DLBCL relapse following rituximab-based chemotherapy." Although lousy data from enzastaurin is a kick in the pants for Eli Lilly, the company still has a promising oncology pipeline...

Diabetes And Oncology Might Cushion Eli Lilly's Fall Off A Patent Cliff [Published Seeking Alpha - May 24 2013]

The results are alarming, Chiang and other experts said. "If these children continue to progress this rapidly, we could see many of the consequences of type 2 diabetes at a much younger age, like kidney disease and heart disease" she said

Type 2 Diabetes Progresses Faster in Kids, Study Finds [Published WebMD - May 24 2013]

More Content

sort by: Date \| Relevance
New Peptide Science Study Results Reported from... [Published NewsRX - 11 hours ago]
Recent Findings in Hormone Research Described b... [Published NewsRX - 11 hours ago]
Popular diabetes drug does not improve survival... [Published NewsRX - 11 hours ago]
Alzheimer's disease hits close to home [Published Fremont Tribune - 18 hours ago]
Diabetes And Oncology Might Cushion Eli Lilly's... [Published Seeking Alpha - May 24 2013]
Insulin's Place In Treatment of Type 2 Diabetes [Published Diabetes in Control - May 24 2013]
Type 2 Diabetes Progresses Faster in Kids, Stud... [Published WebMD - May 24 2013]
Diabetes: an avoidable crisis [Published Pharma Field - May 24 2013]
Youth with type 2 diabetes at much higher risk ... [Published Bio-Medicine - May 24 2013]
Youth with type 2 diabetes at much higher risk ... [Published EurekAlert! - May 24 2013]
Type 2 Diabetes in Kids: 6 New Management Guide... [Published QualityHealth.com - May 24 2013]
Obamacare strikes home [Published Berkshire Eagle - May 24 2013]
Diabetes complications more substantial in youth [Published Nurse.com - May 24 2013]
Type 2 Diabetes in Youth Progresses Faster, Mor... [Published Investors Business Daily - May 23 2013]
Coroner calls for better protocols [Published Otago Daily Times - May 23 2013]
Fetuses Drugged in Attempt to Prevent Obesity [Published Gaia Health - May 23 2013]
Key vildagliptin data in The Lancet show for th... [Published Yahoo! Finance - May 23 2013]
Will Arena's Belviq Be The Next Anti-Obesity Dr... [Published Seeking Alpha - May 23 2013]
AMPK Is Involved in the Regulation of Incretin ... [Published Elites TV - May 23 2013]
Elcelyx Begins Patient Enrolment in Phase IIb ... [Published FDA News - May 23 2013]
NIH Funds Studies to Improve Prediabetes and Ty... [Published PT Community - May 23 2013]
Orexigen Therapeutics' CEO Presents at 2013 UBS... [Published Seeking Alpha - May 22 2013]
Children?s Hospital of Pittsburgh of UPMC Clini... [Published Noodls - May 22 2013]
Standard Chemical & Pharmaceutical Co., Ltd. (1... [Published Live-PR.com - May 22 2013]
NIH funds studies to improve type 2 and prediab... [Published National Institutes of Health - May 22 2013]
Obesity directly tied to several cancers [Published News-Medical.Net - May 22 2013]
Pricing A Highly Probable Takeover Of MannKind [Published Seeking Alpha - May 22 2013]
MSD-Glenmark case to provide clarity on multipl... [Published Individual.com - May 22 2013]
Healthy tips for making recipes diabetes-friendly [Published Taste.com.au - May 22 2013]
We Are About To Change Entertainment [Published AMD Zone - May 21 2013]

sort by: Date \| Relevance
Elcelyx Therapeutics Enrolling Phase 2b Trial o... [Published PR Newswire: Health - May 20 2013]
Takeda and Sanofi Sign Co-promotion Agreement t... [Published Nycomed News RSS feed - Apr 22 2013]
Janssen Submits European Marketing Authorisatio... [Published EON Health & Medicine - Mar 07 2013]
Janssen Submits European Marketing Authorisatio... [Published Business Wire Health News - Mar 07 2013]
Pharmaceutical Company Achieves Positive In-Vit... [Published Financial Services - Jan 31 2013]